Evidence map›Paper›PMID 38300926›Full record

ArticlePhlebology2024

Indications, contraindications, side effects, general assessment, and outlook for the future: An International Compression Club survey.

Mosti Giovanni, Namislo Angrit, Benigni Jean Patrick, Da Matta Eduardo, Partsch Hugo, Schmitz Martin, Abel Martin

Abstract read
In one paragraph

Article in Phlebology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mosti GiovanniAngiology Department, MD Barbantini Clinic, Lucca, Italy.ORCID 0000-0001-7639-8463
Namislo AngritClinical Regulatory Affairs, Lohmann & Rauscher GmbH & Co KG, Neuwied, Germany.
Benigni Jean PatrickFaculty of Medicine, Pitié-Salpétrière, Sorbonne University, Paris, France.
Da Matta EduardoPró Circulação - Clinic of Angiology and Vascular Surgery, Xanxerê, Brazil.
Schmitz MartinMedical Consulting MCS, Oberahr, Germany.
Abel MartinClinical Regulatory Affairs, Lohmann & Rauscher GmbH & Co KG, Neuwied, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effectiveness of compression therapy (CT) and the best compression modality choice are questioned in many clinical stages of chronic venous disease (CVD). This work aims to obtain information on indications, contraindications, and the best treatment option for CT in different clinical scenarios of CVD.

methodAn online survey was made among members of the International Compression Club, experts in CT.

resultsThe experts apply CT in all clinical stages of CVD, even when evidence is missing. Regarding compression materials, experts use inelastic materials in the advanced stages of CVD and compression stockings in the early or chronic stages of CVD.

conclusionThe authors highlight the gap between experts' practical use of CT and evidence-based medicine results. They also suggested that, given the cost of randomized clinical trials aimed at specifying specific indications for different devices, artificial intelligence could be used for large-scale practice surveys in the future.

Indexed as

Stockings, CompressionChronic DiseaseFemaleHumansMaleSurveys and QuestionnairesVenous InsufficiencycommentaryCompression devicescontraindicationsindicationsside effectssurvey

Identifiers

PMID38300926
PMCPMC11129525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.